chrisvoncsefalvay/vaers-outcomes huggingface dataset:
One week after my vaccination I was in Atrial Fibrillation (I was doing pre labs for a surgery).  Also on 15 SEP 2022 (only 2.5 weeks before) I had an EKG at the ER and had a normal sinus rhythm.  Also I?ve always had a normal sinus rhythm and never a cardiac issue.  Also now my diastolic blood pressure is high and was put on Linistril to help with that.
The vaccine was administered to this patient who is under 18 years of age. She did not have any adverse events or symptoms from the vaccine when administered.
Patient was admitted meeting sepsis criteria and received antibiotics and IVF as well as breathing treatments, steroids, and remdesivir for COVID.  Patient's imaging and procalcitonin were not convincing of a bacterial infection and antibiotics were discontinued.  Patient returned to baseline home oxygen requirement and although he becomes very SOB with exertion, this is not abnormal for him.  Patient will be discharged home with prednisone 40mg daily x4 days and instructions to follow up with PCP and pulmonology.   Discharge diagnosis COVID-19 with hypoxia Sepsis COPD exacerbation Insulin-dependent diabetes CAD Hypertension Hyperlipidemia
Diarrhea after Vaccination; Nauseous after Vaccination; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea after Vaccination) and NAUSEA (Nauseous after Vaccination) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced DIARRHOEA (Diarrhea after Vaccination) and NAUSEA (Nauseous after Vaccination). At the time of the report, DIARRHOEA (Diarrhea after Vaccination) and NAUSEA (Nauseous after Vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient had experienced a side effect diarrhea and nauseous. Concomitant medications and treatment were not reported.
Narrative: 70-year-old female with a PMH of T2DM (on empagliflozin) received her booster on 10/1/2021. She experienced frequent urination right after getting the vaccines. No further details documented.
I received a shingles vaccination on Saturday. My arm got red, swollen & hard. An area about 6 inches by 4 inches. Then by Tuesday I had shingles on my neck and back. The pharmacist who gave me the shot said to put hydrocortisone cream on the areas. They said people don't get shingles from the vaccination but I sure did!
Tested positive for COVID Disease & Sick months after 1st booster; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (Tested positive for COVID Disease & Sick months after 1st booster) in a 93-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-May-2022, the patient experienced COVID-19 (Tested positive for COVID Disease & Sick months after 1st booster). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) at an unspecified dose and frequency. At the time of the report, COVID-19 (Tested positive for COVID Disease & Sick months after 1st booster) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-May-2022, SARS-CoV-2 test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  Company Comment: This is a spontaneous case concerning  a  93-year-old, male patient with no reported medical history, who experienced the unexpected non-serious event of Covid-19. The event occurred on May 9, 2022, after the third dose of mRNA-1273 COVID 19 Vaccine which was administered on an unknown date.  Patient tested positive for SARS-CoV-2 test. Patient was treated with Nirmatrelvir/ritonavir at an unspecified dose and frequency. The event outcome was unknown. The benefit-risk relationship of mRNA-1273 COVID 19 Vaccine, is not affected by this report.   This case was linked to MOD-2022-568684, MOD-2022-568296, MOD-2021-024069 (Patient Link).; Sender's Comments: Company Comment: This is a spontaneous case concerning  a  93-year-old, male patient with no reported medical history, who experienced the unexpected non-serious event of Covid-19. The event occurred on May 9, 2022, after the third dose of mRNA-1273 COVID 19 Vaccine which was administered on an unknown date.  Patient tested positive for SARS-CoV-2 test. Patient was treated with Nirmatrelvir/ritonavir at an unspecified dose and frequency. The event outcome was unknown. The benefit-risk relationship of mRNA-1273 COVID 19 Vaccine, is not affected by this report.
Severe swelling in right arm and hives. Entire upper arm involvement. Hot to the touch and extremely painful.
Recieved vaccine in may had two minor stroke  episodes in August,  had normal vital signs but  began having nerve pain and body pain  after receiving the vaccine
He says that he is about 80% better still exhibiting pain in the eyes, H/A, and fatigue. But on the night that he recieved the vaccine, he felt like he had Covid again with chills, fever, and could barely stand. The ambulance was called and they gave him antibiotics and fluids. He has an appt with his doctor Thurs 4/15, I told him that we will follow up on Friday 4/16 to see how his appt went and to check on him.  Ambulance called and rushed to the hospital
Redness at swelling quarter size noted. Informed client to take BENADRYL P.O., ice, BENADRYL cream. States did not do anything just left alone.
flu-like symptoms with primary doses after 2nd dose; mild achiness; site was a letter red and a little tender; site was a letter red and a little tender; feverish; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms with primary doses after 2nd dose), VACCINATION SITE ERYTHEMA (site was a letter red and a little tender), VACCINATION SITE PAIN (site was a letter red and a little tender), PYREXIA (feverish) and PAIN (mild achiness) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 012M20A) for COVID-19 vaccination.     Patient was never diagnosed or tested positive with COVID.  Concurrent medical conditions included Acid reflux (oesophageal), Restless leg syndrome, Hashimoto's thyroiditis (Hashimoto's thyroiditis), Blood pressure high (High Blood pressure), Drug allergy (Sulfa drugs), Iodine contrast media allergy (Iodine contrast) and Seasonal allergy (Seasonal allergies). Concomitant products included OMEPRAZOLE for Acid reflux (oesophageal), HYDROCHLOROTHIAZIDE for Blood pressure high, LEVOTHYROXINE SODIUM (SYNTHROID) and LIOTHYRONINE SODIUM (CYTOMEL) for Hashimoto's thyroiditis, PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE (MIRAPEX) for Restless leg syndrome.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms with primary doses after 2nd dose), VACCINATION SITE ERYTHEMA (site was a letter red and a little tender), VACCINATION SITE PAIN (site was a letter red and a little tender), PYREXIA (feverish) and PAIN (mild achiness). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms with primary doses after 2nd dose), VACCINATION SITE ERYTHEMA (site was a letter red and a little tender), VACCINATION SITE PAIN (site was a letter red and a little tender), PYREXIA (feverish) and PAIN (mild achiness) outcome was unknown.            Patient's height was reported as 5'5.  Patient did not receive any other vaccines prior within 1 month to Moderna vaccination.  Treatment information was not provided by the reporter.   This case was linked to MOD-2022-598147, MOD-2022-598106 (Patient Link).
Pt. states that the night she received the immunization, she had peeling skin, and pustules at the site of injection.
Anaphylaxis; This case was reported by a consumer via other manufacturer and described the occurrence of anaphylaxis in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included urticaria (patient was allergic to Amox and had hives). Concurrent medical conditions included hypertension, nonalcoholic fatty liver disease, obstructive sleep apnea syndrome, gene mutation (heterozygous PRF1 mutation) and penicillin allergy. Concomitant products included levonorgestrel (Mirena Intrauterine Device), sertraline, cetirizine, metoprolol, sennosides (Senna Tabs), magnesium (Magnesium Supplement), colecalciferol (Vitamin D3), paroxetine hydrochloride (Paxil) and spironolactone.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced anaphylaxis (serious criteria GSK medically significant). On an unknown date, the outcome of the anaphylaxis was unknown.   It was unknown if the reporter considered the anaphylaxis to be related to Shingrix.     Additional Information: GSK receipt date: 14-Apr-2022 Reporter's comment: The patient was taking Provigil 250 mg daily for 4 weeks for unknown indication as concomitant medication. Recently, the patient was diagnosed with Covid on 29th March 2022, treated with Pf-07321332, Ritonavir (Paxlovid), 3 tablets twice a day for 5 day and experienced horrid taste in mouth. The reporter consented to follow-up. Additional Supportive Information: It was unknown if the reporter considered the anaphylaxis and hives to be related to Amox.    Note: As this case was received for Pfizer product for Covid which patient had received recently and there is no information regarding the vaccination details of Shingrix, therefore conservatively Shingrix was captured as suspect with event anaphylaxis.
Patient stated 12 hours after receiving vaccine, he had expected side effects, chills, fever, general unwellness, this lasted for a week. One week after getting flu shot he woke up to tongue swelling that progressed and had to go to ER. Patient is also on lisinopril and has been for years, he said Dr believes that he had angioedema from lisinopril that was exacerbated by getting flu shot. Patient had to receive steroids and antihistamines to control swelling, asked us to add both lisinopril and flu shot as allergies.
Nosebleeds have been going on for past 2 days and on Wednesday her friend woke up in pool of blood from nosebleed; Feeling achy, flu-like; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Feeling achy, flu-like) and EPISTAXIS (Nosebleeds have been going on for past 2 days and on Wednesday her friend woke up in pool of blood from nosebleed) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.   On 01-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jun-2021, the patient experienced INFLUENZA LIKE ILLNESS (Feeling achy, flu-like). On 02-Jun-2021, the patient experienced EPISTAXIS (Nosebleeds have been going on for past 2 days and on Wednesday her friend woke up in pool of blood from nosebleed). At the time of the report, INFLUENZA LIKE ILLNESS (Feeling achy, flu-like) and EPISTAXIS (Nosebleeds have been going on for past 2 days and on Wednesday her friend woke up in pool of blood from nosebleed) outcome was unknown.            No treatment was reported.
Information has been received from a licensed practical nurse concerning a 26-year-old white male patient with insulin dependent mellitus who at 11:00 am on 25-Apr-2003 was vaccinated SC in the left arm with a first dose of varicella virus vaccine live (643529/0598M). It was reported that the patient called the primary care physician's office "soon thereafter", on 09-May-2003 and reported a two day history of an itchy rash, "under 50 lesions". The event onset was reported as 07-May-2003. In follow-up the licensed practical nurse reported the patient was being married and he "broke out in chicken pox". It was also noted the patient had multiple raised erythematous papules on his face, neck, abdomen, and back. The licensed practical nurse reported the patient was evaluated by the primary care physician and physician assistant. It was noted the physician had the patient "treat" with calamine lotion (therapy unspecified), and calamine (+) camphor (+) pramoxine hydrochloride (AVEENO) baths. It was noted the patient did not have any illnesses at the time of vaccination, and no laboratory tests were performed. The licensed practical nurse reported patient's outcome is unknown. There was no product quality complain involved. Additional information has been requested.
In the third week of FEB2023 I developed idiopathic peripheral neuropathy. Since then and now continuing until the second week of May 2023 I have been scheduled and attended numerous test including fifteen blood draws seven MRI's and other various exams for at least five different specialist so far nothing determination has been made.
Diarrhea; headache; dizziness; high blood pressure; sore arm; This is a spontaneous report from a non-contactable consumer or other non-health care professional (Patient). A 28-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EP6955 and expiration date was not reported), first dose via an unspecified route of administration, administered in arm right on 26Mar2021 11:00 (at the age of 28 years) single for covid-19 immunisation. The patient's medical history included allergies Shrimp from an unknown date and unknown if ongoing known. Concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19, prior vaccination and since the vaccination. The patient received Birth Control within 2 weeks of vaccination. On 27Mar2021 patient experienced dizziness, headache, high blood pressure, diarrhoea, and a sore arm. Most of the symptoms were gone within 24 hours except for the dizziness and soreness in the arm. Patient continued to feel dizzy, and arm was still sore. Reporter assessed the event as non-serious. Patient received Tylenol as treatment for the adverse events. The outcome of the events dizziness and sore arm are recovering, and other events are recovered on unspecified date of 2021.  No follow-up attempts are possible. No further information is expected.
Swelling and pain of both knees, requiring draining.  Condition reoccurred shortly after initial treatment, requiring referral to rheumatologist.  Pain has now spread to other joints.  Under continuing care and pain treatment for Rheumatoid Arthritis. Had second dose on 07/15/00.
that's the first time I ever caught the flu; Initial information received on 18-Feb-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp.  This case involves patient with unknown demographics who caught the flu while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer with unknown dosage lot number not reported via unknown route in unknown administration site for immunization.  On an unknown date the patient first time ever caught the flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event (that's the first time I ever caught the flu).  At time of reporting, the outcome was Unknown for the event that's the first time i ever caught the flu.
ACUTE COR PULMONALE ACUTE PULMONARY EMBOLISM CHRONIC HYPOXEMIC RESPIRATORY FAILURE
Pt's (L) arm was swollen, red, hot to touch and decrease in ROM. Pt. was treated with a 10 day course of abx. (KEFLEX).
Rash started 10-29-15 in the evening. Rash on both arms, neck, feet. Took OTC BENADRYL daily -> some improvement.
I've not felt well; Hurting all over; Fever 100.4F; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (I've not felt well), PAIN (Hurting all over) and PYREXIA (Fever 100.4F) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (I've not felt well), PAIN (Hurting all over) and PYREXIA (Fever 100.4F). At the time of the report, MALAISE (I've not felt well), PAIN (Hurting all over) and PYREXIA (Fever 100.4F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: 100.4 (High) Fever 100.4F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication was provided. No Treatment medications were reported.
This patient had a generalized maculo-papular rash on 12/28/00. After given vaccines on 12/22/00 afebrile , no shortness of breath.
FATIGUE; NECKACHE; CHILLS; MUSCLE ACHES; HEADACHE; DRENCHED IN SWEAT; This spontaneous report received from a patient via a company representative concerned a 51 year old male. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection, and concurrent conditions included hypertension, and other pre-existing medical conditions included no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, and expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 15:45 for prophylactic vaccination. No concomitant medications were reported. On 13-APR-2021, the subject experienced drenched in sweat. On 13-APR-2021, the subject experienced headache. Treatment medications included: paracetamol. On 13-APR-2021 01:00, the subject experienced chills. On 13-APR-2021 01:00, the subject experienced muscle aches. On 13-APR-2021 05:00, the subject experienced neckache. On 13-APR-2021 06:00, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from drenched in sweat, chills, and muscle aches on 13-APR-2021, was recovering from neckache, and had not recovered from headache, and fatigue. This report was non-serious.
Pain in left arm the day after vaccination that escalated over the next few days; warm feeling in arm from shoulder to elbow; still having trouble lifting arm
In bed for 10 days; Arm got very hot; Fever; Bad swelling in the left arm, Arm swell up; This spontaneous case was reported by a patient and describes the occurrence of ILLNESS (In bed for 10 days), VACCINATION SITE WARMTH (Arm got very hot), PYREXIA (Fever) and VACCINATION SITE SWELLING (Bad swelling in the left arm, Arm swell up) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013F21A, 006M20A and QFA2036) for COVID-19 prophylaxis.     Concurrent medical conditions included Allergy (she is taking allergy pills). Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (In bed for 10 days), VACCINATION SITE WARMTH (Arm got very hot), PYREXIA (Fever) and VACCINATION SITE SWELLING (Bad swelling in the left arm, Arm swell up). At the time of the report, ILLNESS (In bed for 10 days), VACCINATION SITE WARMTH (Arm got very hot), PYREXIA (Fever) and VACCINATION SITE SWELLING (Bad swelling in the left arm, Arm swell up) had resolved.            Patient is not taking other medication except for allergy pills and aspirin once in a while. No Medical history relating to mentioned AE and both Acute and Chronic illnesses at the time of vaccination.  Patient had no Allergies with medications, food and other products.  The doctor gave the patient antibiotic. The emergency clinic gave her another one and a shot in the hip.   This case was linked to MOD-2022-659373 (Patient Link).
Pt left office after receiving MMR #1, Varicella #1, Hib #4, 20 minutes later Mom returned with child. No tonic -clonic activity no color change, but eyes rolled in head (per Mom) child examined and examined per Dr.
tiredness; joint ache; hair ache / scalp hurts; Back pain; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a elderly patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included bell's palsy. Previously administered products included Shingrix with an associated reaction of fatigue (1st dose received on 12th March 2019 and experienced adverse events, refer linked case US2019134786).   On 23rd July 2019, the patient received the 2nd dose of Shingrix. On 24th July 2019, 1 days after receiving Shingrix, the patient experienced tiredness, joint pain, scalp pain and back pain. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the tiredness, joint pain, scalp pain and back pain were unknown.   It was unknown if the reporter considered the tiredness, joint pain, scalp pain and back pain to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The patient received Shingrix on left arm. On the reporting date, the patient experienced adverse events which were back pain, joint pain, tiredness, hair hurt, and scalp hurts.